Secukinumab Delivers Sustained Remission and Toxicity Reduction in PMR
For the majority of patients with polymyalgia rheumatica, glucocorticoids do not provide a durable solution. They induce remission, but they do not maintain it. REPLENISH, the largest PMR clinical ...
Six Months on Steroids: The Point at Which Toxicity Becomes Undeniable
A new prospective study published in Seminars in Arthritis and Rheumatism confirms what clinicians have long known but have been unable to quantify: steroid-toxicity is universal in patients on ...
Why Steroid Dose Alone Cannot Define Steroid-Sparing Value in Asthma Development
Approximately 13 million people worldwide have severe, uncontrolled asthma even with optimized treatment, according to the Global Initiative for Asthma (GINA). In this population, systemic steroid ...
Measuring What Matters: Steroid-toxicity and Patient Outcomes
Ten years ago, two clinical researchers walked into a bar and, over a beer, asked themselves whether the direct measurement of steroid-toxicity would ever be possible. Today, Steritas, in licensing ...
The Trials Driving the Next Wave of Steroid-Sparing Innovation
A wave of clinical trial results using the STOX® Suite of clinical outcome assessments (COAs) in a range of diseases will soon reach the shore, helping to deliver new therapeutic options for ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
